Source recordFED

Keown, Paul A

Federal grants & contributions· Canadian Institutes of Health Research· FY2018· $2,598,775· BC

Description

Precision Medicine CanPREVENT AMR: Applying Precision Medicine Technologies in Canada to Prevent Antibody Mediated Rejection and Premature Kidney Transplant Loss

Amendment chain · 1 entry

Each notch is one published row for this agreement: #0 is the original (placed at its start date) and each later notch is an amendment (placed at its amendment date). The height is the agreement's total value as of that row — the source column is cumulative, not a change amount — so the line reads as the commitment over time and the right-most notch is the current commitment shown in the header.

$2,598,775$0Original · 2017-11-01 (start date) · total $2,598,775
  • #02017-11-01$2,598,775
RowDateTotal value as of rowChange vs previousDescription on this row
#0 original2017-11-01(start date)$2,598,775—Precision Medicine CanPREVENT AMR: Applying Precision Medicine Technologies in Canada to Prevent Antibody Medi…

Cite as: Glassbox record view · Federal grants & contributions · 236-2017-2018-Q4-00904 · retrieved 2026-11-14.